B-type natriuretic peptide, also known as brain natriuretic peptide, BNP is mainly synthesized and secreted by ventricular myocytes, and changes in ventricular load and wall tension are the main conditions to stimulate BNP secretion. BNP can promote the excretion of sodium and urination, and has a strong vasodilator effect. B-type natriuretic peptide is usually significantly elevated in patients with atrial fibrillation and heart failure, and BNP is currently one of the most common biomarkers of heart failure in clinical use
Detection range | sample size | Sample type | Test time |
5~5000pg/mL | 60μl | Plasma / whole blood | 15min |
BNP | Suggestions for clinical application |
<100pg/mL | HF is very unlikely |
100-400pg/mL | Heart failure may be low and diagnosed in combination with other clinical manifestations |
>400pg/mL | HF is likely |
Cardiology, emergency department, Nephrology, respiratory medicine, etc
Zhongxiu Science And Technology Co.,Ltd., is a high-tech enterprise engaged in the research and development, production and operation of in vitro diagnostic products. The in vitro diagnostic products developed by the company cover POCT series, microbial series, biochemical series and immune series reagents and supporting instruments.
The company has always adhered to the core concept of "fast and accurate, living up to life", committed to providing society with excellent products and services, and contributing to the cause of human health.